Validation of cardiotoxicity screening model established by human iPSC-derived cardiomyocytes based on real time cellular analysis

CHEN Gao-jian, PAN Dong-sheng, CHEN Si-rong, ZHANG Ying-li, LI Qian-qian, SHI Xi-xi, WANG Xue, HUANG Zhi-ying, WANG San-long

doi:10.16155/j.0254-1793.2020.01.13

Chinese Journal of Pharmaceutical Analysis >

2020 , Vol. 40 >Issue 1: 90 - 103

DOI: https://doi.org/10.16155/j.0254-1793.2020.01.13

Validation of cardiotoxicity screening model established by human iPSC-derived cardiomyocytes based on real time cellular analysis

Expand

1. Beijing Key Laboratory, National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 100176, China;
2. School of Pharmaceutical Science, Sun Yat-sen University, Guangzhou 510006, China

Online published: 2024-05-31

Fold

Cite this article

CHEN Gao-jian, PAN Dong-sheng, CHEN Si-rong, ZHANG Ying-li, LI Qian-qian, SHI Xi-xi, WANG Xue, HUANG Zhi-ying, WANG San-long . Validation of cardiotoxicity screening model established by human iPSC-derived cardiomyocytes based on real time cellular analysis[J]. Chinese Journal of Pharmaceutical Analysis, 2020 , 40(1) : 90 -103 . DOI: 10.16155/j.0254-1793.2020.01.13

Options

Abstract

Outlines

模态框（Modal）标题

Cite this article